Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Total Debt (2017)

Historic Total Debt for Aclaris Therapeutics (ACRS) over the last 1 years, with Q4 2017 value amounting to $590000.0.

  • Aclaris Therapeutics' Total Debt changed N/A to $590000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $590000.0, marking a year-over-year change of. This contributed to the annual value of $590000.0 for FY2017, which is N/A changed from last year.
  • Latest data reveals that Aclaris Therapeutics reported Total Debt of $590000.0 as of Q4 2017.
  • Over the past 5 years, Aclaris Therapeutics' Total Debt peaked at $590000.0 during Q4 2017, and registered a low of $590000.0 during Q4 2017.